Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-24 @ 2:52 PM
NCT ID:
NCT01609959
Eligibility Criteria:
Inclusion Criteria:
* Hypertensive patients treated with normal-dose angiotensin II receptor blockers (ARBs) in Japan
* Normal-dose ARBs in Japan are defined as follows: losartan potassium 50 mg, candesartan cilexetil 8 mg, valsartan 80 mg, telmisartan 40 mg, olmesartan medoxomil 20 mg, or irbesartan 100mg per day.
Exclusion Criteria:
* Hypersensitivity for azilsartan and valsartan
* Pregnant female
* History of azilsartan use within 3 months
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01609959
Study Brief:
Protocol Section:
NCT01609959